Stocksigma LogoStocksigma Logo

Senores Pharmaceuticals Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Crore)

■ Revenue: 192 (+24.9% YoY | +6.7% QoQ) ■ EBITDA: 57.7 (+38.3% YoY | +7.3% QoQ) ■ EBITDA Margin (%): 30.0 (+290 bps YoY | +15 bps QoQ) ■ PAT: 39.5 (+22.0%

Senores Pharmaceuticals Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Crore)

Senores Pharmaceuticals Ltd · Outcome · 29 Oct 2026, 7:22 pm

Senores Pharmaceuticals Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Crore) ■ Revenue: 192 (+24.9% YoY | +6.7% QoQ) ■ EBITDA: 57.7 (+38.3% YoY | +7.3% QoQ) ■ EBITDA Margin (%): 30.0 (+290 bps YoY | +15 bps QoQ) ■ PAT: 39.5 (+22.0% YoY | +28.5% QoQ) ■ EPS (INR): 8.82 (+34.9% YoY | +33.6% QoQ)

Original exchange filing (PDF)

More announcements from Senores Pharmaceuticals Ltd

All Senores Pharmaceuticals Ltd announcements